Well differentiated neuroendocrine tumors, a single center experienceEce Esin, Berna Oksuzoglu, Erkan Erdur, Guliz Ozgun, Umut DemirciUniversity of Health Sciences, Dr. A.Y Ankara Oncology Education and Research Hospital, Department of Medical Oncology, Demetevler, Ankara, TurkeyDOI: 10.1016/j.jons.2018.10.002 Pages: 119 - 124 1796 Viewed.
Experience from Turkish centers participating in the Early Access Program (EAP): Preliminary real-world safety data of nivolumab (nivo) combined with ipilimumab (ipi) in pre-treated advanced melanoma patientsNuri Karadurmus a,* , Mehmet Ali Nahit Sendur b, Burcak Karacac, Omer Fatih Olmezd, Ilhan Hacibekiroglu e, Hasan Senol Coskunf, Serkan Degirmencioglu g, Yasemin Kemal h,Saadettin Kilickapi, Ahmet Taner Sumbul j, Burc Aydink, Hande Turnal, Muhammet Ali Kaplanm,Nalan Babacann, Umut Demirci o, Alper Atap, Dilek Erdemq, Ahmet Ozet r, Huseyin Abali sa Health Sciences University, Gulhane Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey
b Ankara Yıldırım Beyazıt University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
c Ege University, Faculty of Medicine, Department of Medical Oncology, Izmir, Turkey
d Medipol Mega Hospitals Complex, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey
e Sakarya University, Faculty of Medicine, Department of Medical Oncology, Sakarya, Turkey
f Akdeniz University, Faculty of Medicine, Department of Medical Oncology, Antalya, Turkey
g Pamukkale University, Faculty of Medicine, Department of Medical Oncology, Denizli, Turkey
h Ondokuz Mayıs University, Faculty of Medicine, Department of Medical Oncology, Samsun, Turkey
i Hacettepe University Cancer Institute, Department of Medical Oncology, Ankara, Turkey
j Baskent University Faculty of Medicine, Department of Medical Oncology, Adana, Turkey
k Medical Science Liaison, Bristol Myers Squib, Istanbul, Turkey
l Istanbul Cerrahpasa University, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey
m Dicle University, Faculty of Medicine, Department of Medical Oncology, Diyarbakır, Turkey
n MarmaraUniversity, Faculty of Medicine, Department of Medical Oncology, Istanbul, Turkey
oUniversity of Health Sciences, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey
p Medical Park Tarsus Hospital, Department of Medical Oncology, Mersin, Turkey
qMedical Park Samsun Hospital, Department of Medical Oncology, Samsun, Turkey
rGazi University, Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey
sAcıbadem University, Faculty of Medicine, Department of Medical Oncology, Istanbul, TurkeyDOI: 10.1016/j.jons.2018.10.001 Pages: 125 - 129 1563 Viewed.
Risk factors for thrombosis risk in patients with cancerDilara Turana, Hatime Arzu Yasarb, Ozge Bas Aksua, Elif Berna Koksoyc, Gungor Utkanb, Hakan Akbulutb, Yuksel UrunbaAnkara University School of Medicine, Department of Internal Medicine, Ankara, Turkey
bAnkara University School of Medicine, Department of Medical Oncology, Ankara, Turkey
cKastamonu State Hospital, Department of Medical Oncology, Kastamomu, TurkeyDOI: 10.1016/j.jons.2018.09.001 Pages: 130 - 133 1450 Viewed.
"Squamos cell lung cancer" case applying with dyspepsia complaintsSema Turker, Hayriye Sahinli, Perihan Perkin, Dogan Yazilitas, Nimet Oge Koklu, Goksen Inanc Imamoglu, Cengiz Karacin, Mustafa AltinbasDiskapi Yildirim Beyazit Training and Research Hospital, Medical Oncology Department, Ankara, TurkeyDOI: 10.1016/j.jons.2018.08.001 Pages: 147 - 148 1472 Viewed.